Radiotherapy for Prostate Cancer: 2- vs 8-Week Course

1. HYPO-RT-PC trial: 2-week radiotherapy for prostate cancer vs 8-week schedule 2. 10-year study shows no compromise in outcomes and safety 3. Shorter treatment may reduce disruption to daily life and lower healthcare costs 4. Key outcomes after 10 years: failure-free survival, overall survival, prostate cancer–specific mortality, and side effects 5. Modern radiotherapy making treatment more efficient, accessible, and patient-friendly